Bellevue Life Sciences Acquisition (BLAC) Competitors $11.60 -0.07 (-0.60%) (As of 11/20/2024 ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends BLAC vs. SKIN, SONX, KRMD, BWAY, DRTS, ZJYL, NVRO, LAKE, PDEX, and SRTSShould you be buying Bellevue Life Sciences Acquisition stock or one of its competitors? The main competitors of Bellevue Life Sciences Acquisition include Beauty Health (SKIN), Sonendo (SONX), KORU Medical Systems (KRMD), BrainsWay (BWAY), Alpha Tau Medical (DRTS), Jin Medical International (ZJYL), Nevro (NVRO), Lakeland Industries (LAKE), Pro-Dex (PDEX), and Sensus Healthcare (SRTS). These companies are all part of the "medical equipment" industry. Bellevue Life Sciences Acquisition vs. Beauty Health Sonendo KORU Medical Systems BrainsWay Alpha Tau Medical Jin Medical International Nevro Lakeland Industries Pro-Dex Sensus Healthcare Beauty Health (NASDAQ:SKIN) and Bellevue Life Sciences Acquisition (NASDAQ:BLAC) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their risk, community ranking, profitability, earnings, institutional ownership, analyst recommendations, valuation, dividends and media sentiment. Is SKIN or BLAC more profitable? Bellevue Life Sciences Acquisition has a net margin of 0.00% compared to Beauty Health's net margin of -8.11%. Bellevue Life Sciences Acquisition's return on equity of 0.00% beat Beauty Health's return on equity.Company Net Margins Return on Equity Return on Assets Beauty Health-8.11% -44.83% -3.54% Bellevue Life Sciences Acquisition N/A N/A N/A Which has higher valuation and earnings, SKIN or BLAC? Bellevue Life Sciences Acquisition has lower revenue, but higher earnings than Beauty Health. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBeauty Health$398M0.46-$100.12M-$0.42-3.55Bellevue Life Sciences AcquisitionN/AN/AN/AN/AN/A Do insiders & institutionals believe in SKIN or BLAC? 93.3% of Beauty Health shares are held by institutional investors. Comparatively, 55.3% of Bellevue Life Sciences Acquisition shares are held by institutional investors. 41.0% of Beauty Health shares are held by insiders. Comparatively, 33.7% of Bellevue Life Sciences Acquisition shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term. Which has more risk and volatility, SKIN or BLAC? Beauty Health has a beta of 0.9, meaning that its stock price is 10% less volatile than the S&P 500. Comparatively, Bellevue Life Sciences Acquisition has a beta of -0.05, meaning that its stock price is 105% less volatile than the S&P 500. Does the media favor SKIN or BLAC? In the previous week, Beauty Health had 11 more articles in the media than Bellevue Life Sciences Acquisition. MarketBeat recorded 13 mentions for Beauty Health and 2 mentions for Bellevue Life Sciences Acquisition. Beauty Health's average media sentiment score of 1.01 beat Bellevue Life Sciences Acquisition's score of 0.00 indicating that Beauty Health is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Beauty Health 9 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Bellevue Life Sciences Acquisition 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Do analysts recommend SKIN or BLAC? Beauty Health currently has a consensus price target of $2.55, suggesting a potential upside of 71.14%. Given Beauty Health's stronger consensus rating and higher probable upside, equities analysts plainly believe Beauty Health is more favorable than Bellevue Life Sciences Acquisition.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Beauty Health 1 Sell rating(s) 3 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00Bellevue Life Sciences Acquisition 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Does the MarketBeat Community favor SKIN or BLAC? Beauty Health received 40 more outperform votes than Bellevue Life Sciences Acquisition when rated by MarketBeat users. CompanyUnderperformOutperformBeauty HealthOutperform Votes4045.98% Underperform Votes4754.02% Bellevue Life Sciences AcquisitionN/AN/A SummaryBeauty Health beats Bellevue Life Sciences Acquisition on 10 of the 13 factors compared between the two stocks. Ad Wide Moat ResearchTrump said you could learn something from this manEarly Warning: A Deep Crack Is Forming In The US Economy Stocks are booming thanks to Trump’s landslide victory. Yet one former Trump advisor says the picture is less rosy than it seems. “I’ve found a deep crack forming in the foundations of the US economy,” he says. “And before too long, it could tear our country apart.” It’s critical you learn more today, BEFORE it impacts your money and your retirement. Here’s everything you need to know. Get Bellevue Life Sciences Acquisition News Delivered to You Automatically Sign up to receive the latest news and ratings for BLAC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BLAC vs. The Competition Export to ExcelMetricBellevue Life Sciences AcquisitionHolding Offices IndustryUnclassified SectorNASDAQ ExchangeMarket Cap$46.86M$264.94M$108.12M$8.90BDividend YieldN/A7.57%5.20%4.07%P/E RatioN/A2.161.0713.46Price / SalesN/A155.741.2387.66Price / CashN/A80.91100.1736.27Price / BookN/A73.36519.866.30Net IncomeN/A$32.24M$2.82M$225.93M7 Day Performance-5.31%-0.21%-0.19%-1.32%1 Month Performance6.03%-4.81%-3.22%0.60%1 Year Performance11.11%14.31%15.40%26.23% Bellevue Life Sciences Acquisition Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BLACBellevue Life Sciences AcquisitionN/A$11.60-0.6%N/A+11.0%$46.86MN/A0.00N/AHigh Trading VolumeSKINBeauty Health2.7023 of 5 stars$1.49-7.5%$2.55+71.1%-36.3%$184.79M$398M0.001,030Analyst RevisionPositive NewsSONXSonendoN/A$2.16+1.4%N/A+815.3%$180.60M$44.40M-4.80250Positive NewsGap UpKRMDKORU Medical Systems2.0124 of 5 stars$3.65+10.3%$4.13+13.0%+60.1%$167.32M$28.52M0.0080BWAYBrainsWay3.9884 of 5 stars$9.83+1.7%$13.17+33.9%+103.9%$163.96M$31.78M98.31120Gap UpDRTSAlpha Tau Medical2.3971 of 5 stars$2.30flat$8.00+248.6%-20.7%$159.89MN/A0.0080ZJYLJin Medical InternationalN/A$1.03+2.0%N/A-94.1%$159.65M$19.82M0.00245Positive NewsGap DownNVRONevro2.8885 of 5 stars$4.23-0.2%$9.10+115.1%-74.5%$158.50M$425.17M-2.241,215Analyst UpgradeGap DownLAKELakeland Industries4.4003 of 5 stars$21.14-2.0%$26.50+25.4%+44.7%$156.44M$124.69M88.081,750PDEXPro-Dex1.5482 of 5 stars$45.75-3.9%$52.00+13.7%+174.5%$149.15M$53.84M30.93140SRTSSensus Healthcare4.0682 of 5 stars$9.00+0.7%$12.50+38.9%+331.9%$147.51M$24.41M15.6840Analyst ForecastAnalyst Revision Related Companies and Tools Related Companies SKIN Competitors SONX Competitors KRMD Competitors BWAY Competitors DRTS Competitors ZJYL Competitors NVRO Competitors LAKE Competitors PDEX Competitors SRTS Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:BLAC) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredBut another coin could soar even higher …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bellevue Life Sciences Acquisition Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bellevue Life Sciences Acquisition With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BLAC Stock Alerts